CLINICAL_TRIALS
trial_result
· 2011-09-22
Clinical Trial Update: A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus [Phase 1]
Summary
A Phase 1 trial evaluating rhuMAb IFNalpha in adults with systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED